Registered Trials
-
CTRI/2021/10/037269
Phase 2/3India
Total Enrollment: 1,600
Official Trial Registration:
-
NCT04681092
Phase 1/2Netherlands
Total Enrollment: 130
Official Trial Registration:
Vaccine Type: Protein Subunit
This vaccine has reached Phase 3 trials.
This vaccine is not yet approved.
India
Total Enrollment: 1,600
Netherlands
Total Enrollment: 130
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.